ホーム>>Signaling Pathways>> GPCR/G protein>> Leukotriene Receptor>>(S)-Verapamil hydrochloride

(S)-Verapamil hydrochloride

カタログ番号GC60008

(S)-ベラパミル塩酸塩 (S(-)-ベラパミル塩酸塩) は、MRP1 によるロイコトリエン C4 (LTC4) およびカルセイン輸送を阻害します。 (S)-ベラパミル塩酸塩は、潜在的に耐性のある腫瘍細胞を死滅させます。

Products are for research use only. Not for human use. We do not sell to patients.

(S)-Verapamil hydrochloride 化学構造

Cas No.: 36622-28-3

サイズ 価格 在庫数 個数
5mg
$225.00
在庫あり
10mg
$375.00
在庫あり
25mg
$713.00
在庫あり
50mg
$1,125.00
在庫あり
100mg
$1,688.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells[1].

(S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) not the (R)-Verapamil hydrochloride potently induces the death of MRP1-transfected BHK-21 cells[1]. (S)-Verapamil hydrochloride is good active form and has the low bioavailability[1].

[1]. Perrotton T, et al. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J Biol Chem. 2007 Oct 26;282(43):31542-8. Epub 2007 Jul 22. [2]. Tannergren C, et al. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther. 2004 Apr;75(4):298-309.

レビュー

Review for (S)-Verapamil hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (S)-Verapamil hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.